160 related articles for article (PubMed ID: 30273383)
1. A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia.
Jäkel F; Worm O; Lange S; Mertelsmann R
PLoS One; 2018; 13(10):e0204393. PubMed ID: 30273383
[TBL] [Abstract][Full Text] [Related]
2. The molecular pathogenesis of acute myeloid leukemia.
Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
[TBL] [Abstract][Full Text] [Related]
3. MYCN transgenic zebrafish model with the characterization of acute myeloid leukemia and altered hematopoiesis.
Shen LJ; Chen FY; Zhang Y; Cao LF; Kuang Y; Zhong M; Wang T; Zhong H
PLoS One; 2013; 8(3):e59070. PubMed ID: 23554972
[TBL] [Abstract][Full Text] [Related]
4. Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Ghosh K; Madkaikar M
Leuk Lymphoma; 2016 Sep; 57(9):2195-8. PubMed ID: 26700494
[No Abstract] [Full Text] [Related]
5. A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry.
Capolunghi F; Capponi C; De Stefani B; Luciani M; Locatelli F; Muraca M; Carsetti R
Am J Hematol; 2014 Mar; 89(3):343-4. PubMed ID: 24265183
[No Abstract] [Full Text] [Related]
6. Uncommon phenotypes of acute myelogenous leukemia: basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: a review.
Lichtman MA; Segel GB
Blood Cells Mol Dis; 2005; 35(3):370-83. PubMed ID: 16203163
[TBL] [Abstract][Full Text] [Related]
7. Leukemic blast cells and controversies in models of hematopoiesis.
Gluzman DF; Sklyarenko LM; Zavelevich MP; Koval SV; Ivanovskaya TS
Exp Oncol; 2015 Mar; 37(1):2-4. PubMed ID: 25804223
[TBL] [Abstract][Full Text] [Related]
8. [Pathobiology of acute myeloid leukemia].
Christ O; Feuring-Buske M; Hiddemann W; Buske C
Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
[TBL] [Abstract][Full Text] [Related]
9. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
10. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into early hematopoiesis.
Mead PE; Zon LI
Curr Opin Hematol; 1998 Mar; 5(2):156-60. PubMed ID: 9570710
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
Somervaille TC; Cleary ML
Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
[TBL] [Abstract][Full Text] [Related]
14. Loss of Asxl2 leads to myeloid malignancies in mice.
Li J; He F; Zhang P; Chen S; Shi H; Sun Y; Guo Y; Yang H; Man N; Greenblatt S; Li Z; Guo Z; Zhou Y; Wang L; Morey L; Williams S; Chen X; Wang QT; Nimer SD; Yu P; Wang QF; Xu M; Yang FC
Nat Commun; 2017 Jun; 8():15456. PubMed ID: 28593990
[TBL] [Abstract][Full Text] [Related]
15. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
Schuster MB; Porse BT
Biofactors; 2009; 35(3):227-31. PubMed ID: 19322763
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Horiguchi H; Kobune M; Kikuchi S; Yoshida M; Murata M; Murase K; Iyama S; Takada K; Sato T; Ono K; Hashimoto A; Tatekoshi A; Kamihara Y; Kawano Y; Miyanishi K; Sawada N; Kato J
Haematologica; 2016 Apr; 101(4):437-47. PubMed ID: 26802051
[TBL] [Abstract][Full Text] [Related]
17. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.
Puram RV; Kowalczyk MS; de Boer CG; Schneider RK; Miller PG; McConkey M; Tothova Z; Tejero H; Heckl D; Järås M; Chen MC; Li H; Tamayo A; Cowley GS; Rozenblatt-Rosen O; Al-Shahrour F; Regev A; Ebert BL
Cell; 2016 Apr; 165(2):303-16. PubMed ID: 27058663
[TBL] [Abstract][Full Text] [Related]
18. Lineage-specific transcription factor aberrations in AML.
Mueller BU; Pabst T
Cancer Treat Res; 2010; 145():109-25. PubMed ID: 20306248
[TBL] [Abstract][Full Text] [Related]
19. Enforced expression of the homeobox gene Mixl1 impairs hematopoietic differentiation and results in acute myeloid leukemia.
Glaser S; Metcalf D; Wu L; Hart AH; DiRago L; Mifsud S; D'Amico A; Dagger S; Campo C; Chan AC; Izon DJ; Robb L
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16460-5. PubMed ID: 17060613
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors.
Habif G; Grasset MF; Kieffer-Jaquinod S; Kuhn L; Mouchiroud G; Gobert-Gosse S
J Proteomics; 2013 Jan; 78():231-44. PubMed ID: 23017497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
